Skip to main content
. 2017 Dec 4;8(66):110326–110336. doi: 10.18632/oncotarget.22887

Table 6. Stratified analyses between MTHFR rs4845882 G>A polymorphism and NSCLC risk by sex, age, BMI, smoking status and alcohol consumption.

Variable MTHFR rs4845882 G>A (case/control)a Adjusted ORb (95% CI); P
GG GA AA GG GA AA GA /AA AA vs. (GA/GG)
Sex
Male 177/349 94/212 16/26 1.00 0.87 (0.63–1.21);P: 0.411 1.42 (0.71–2.85);P: 0.322 0.93 (0.68–1.26);P: 0.627 1.49 (0.75–2.96);P: 0.254
Female 132/283 97/142 5/17 1.00 1.47 (1.05–2.05);P: 0.025 0.68 (0.24–1.90);P: 0.460 1.39 (1.00–1.93);P: 0.051 0.59 (0.21–1.63);P: 0.304
Age
<60 136/286 92/169 10/20 1.00 1.17 (0.83–1.65);P: 0.361 1.15 (0.50–2.61);P: 0.746 1.17 (0.84–1.63);P: 0.359 1.08 (0.48–2.42);P: 0.862
≥60 173/346 99/185 11/23 1.00 1.07 (0.78–1.47);P: 0.685 1.12 (0.52–2.43);P: 0.777 1.07 (0.79–1.46);P: 0.653 1.09 (0.51–2.35);P: 0.820
Smoking status
Never 186/510 119/282 12/35 1.00 1.16 (0.88–1.53);P: 0.301 1.09 (0.54–2.18);P: 0.815 1.15 (0.88–1.51);P: 0.313 1.03 (0.52–2.04);P: 0.940
Ever 123/122 72/72 9/8 1.00 1.02 (0.68–1.55);P: 0.914 1.21 (0.45–3.27);P: 0.705 1.04 (0.70–1.56);P: 0.842 1.20 (0.45–3.20);P: 0.714
Alcohol consumption
Never 260/581 168/327 16/40 1.00 1.14 (0.89–1.45);P: 0.312 0.99 (0.53–1.85);P: 0.982 1.12 (0.88–1.42);P: 0.354 0.95 (0.51–1.75);P: 0.858
Ever 49/51 23/27 5/3 1.00 0.95 (0.47–1.92);P: 0.893 2.23 (0.47–10.67);P: 0.315 1.06 (0.54–2.08);P: 0.858 2.27 (0.48–10.64);P: 0.298
BMI (kg/m2)
< 24 207/338 120/190 10/18 1.00 1.06 (0.78–1.42);P: 0.724 1.03 (0.45–2.35);P: 0.952 1.05 (0.79–1.41);P: 0.737 1.00 (0.44–2.28);P: 0.992
≥ 24 102/294 71/164 11/25 1.00 1.24 (0.85–1.79);P: 0.262 1.26 (0.58–2.72);P: 0.557 1.24 (0.87–1.77);P: 0.236 1.16 (0.55–2.48);P: 0.697

a The genotyping was successful in 521 (100.00%) NSCLC cases, and 1030 (99.90%) controls for MTHFR rs4845882 G>A;

b Adjusted for age, sex, BMI, smoking status and alcohol consumption (besides stratified factors accordingly) in a logistic regression model;